Us Bancorp \De\ Nevro Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Nevro Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 11,348 shares of NVRO stock, worth $37,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,348

Previous 829 1268.88%

Holding current value

$37,334

Previous $6,000 950.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$4.71 - $10.1 $49,544 - $106,241	10,519 Added 1268.88%	11,348 $63,000
Q2 2024 Aug 06, 2024	SELL	$7.96 - $13.59 $3,176 - $5,422	-399 Reduced 32.49%	829 $6,000
Q1 2024 May 07, 2024	SELL	$13.56 - $20.78 $11,227 - $17,205	-828 Reduced 40.27%	1,228 $17,000
Q4 2023 Feb 09, 2024	SELL	$14.18 - $22.31 $10,620 - $16,710	-749 Reduced 26.7%	2,056 $44,000
Q3 2023 Nov 03, 2023	BUY	$18.22 - $25.85 $37,132 - $52,682	2,038 Added 265.71%	2,805 $53,000
Q2 2023 Aug 09, 2023	BUY	$22.62 - $39.32 $6,288 - $10,930	278 Added 56.85%	767 $19,000
Q1 2023 May 09, 2023	BUY	$30.17 - $41.11 $14,753 - $20,102	489 New	489 $17,000
Q3 2022 Oct 27, 2022	SELL	$40.66 - $53.03 $6,058 - $7,901	-149 Reduced 29.39%	358 $17,000
Q2 2022 Aug 01, 2022	BUY	$40.85 - $77.67 $15,604 - $29,669	382 Added 305.6%	507 $22,000
Q1 2022 May 11, 2022	SELL	$59.95 - $92.06 $4,196 - $6,444	-70 Reduced 35.9%	125 $9,000
Q4 2021 Feb 11, 2022	BUY	$81.07 - $121.29 $15,808 - $23,651	195 New	195 $15,000
Q1 2021 Apr 28, 2021	SELL	$132.81 - $182.18 $796 - $1,093	-6 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$138.17 - $184.34 $829 - $1,106	6 New	6 $1,000
Q3 2020 Nov 10, 2020	SELL	$114.09 - $145.51 $114 - $145	-1 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$70.23 - $144.31 $1,685 - $3,463	-24 Reduced 96.0%	1 $0
Q3 2019 Nov 08, 2019	SELL	$61.52 - $91.1 $9,904 - $14,667	-161 Reduced 86.56%	25 $2,000
Q2 2019 Aug 13, 2019	SELL	$58.04 - $66.99 $18,630 - $21,503	-321 Reduced 63.31%	186 $12,000
Q1 2019 May 08, 2019	SELL	$35.52 - $62.62 $11,295 - $19,913	-318 Reduced 38.55%	507 $31,000
Q4 2018 Feb 13, 2019	SELL	$35.43 - $56.29 $115,324 - $183,223	-3,255 Reduced 79.78%	825 $32,000
Q3 2018 Nov 01, 2018	SELL	$44.22 - $75.47 $67,258 - $114,789	-1,521 Reduced 27.16%	4,080 $232,000
Q2 2018 Aug 08, 2018	BUY	$72.38 - $92.5 $30,761 - $39,312	425 Added 8.21%	5,601 $447,000
Q1 2018 May 08, 2018	BUY	$69.46 - $88.57 $44,871 - $57,216	646 Added 14.26%	5,176 $449,000
Q4 2017 Feb 02, 2018	BUY	$65.94 - $93.31 $38,179 - $54,026	579 Added 14.65%	4,530 $313,000
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $319,517 - $359,857	3,951	3,951 $359,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account